ACI
IBB icon

Alpha Cubed Investments’s iShares Biotechnology ETF IBB Stock Holding History

Alpha Cubed Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,422
Closed -$296K – 293
2023
Q3 		$296K Sell
2,422
-45,495
-95% -$5.79M 0.02% 184
2023
Q2 		$6.08M Buy
47,917
+2,365
+5% +$307K 0.41% 58
2023
Q1 		$5.88M Buy
45,552
+32,827
+258% +$4.3M 0.43% 60
2022
Q4 		$1.67M Buy
12,725
+10,679
+522% +$1.38M 0.13% 97
2022
Q3 		$239K Buy
2,046
+50
+3% +$6.21K 0.02% 216
2022
Q2 		$235K Sell
1,996
-498
-20% -$59.1K 0.02% 268
2022
Q1 		$325K Sell
2,494
-88,437
-97% -$11.5M 0.02% 249
2021
Q4 		$13.9M Buy
90,931
+21,390
+31% +$3.31M 0.91% 39
2021
Q3 		$11.2M Buy
69,541
+2,636
+4% +$444K 0.85% 40
2021
Q2 		$10.9M Buy
66,905
+10,459
+19% +$1.61M 0.79% 43
2021
Q1 		$8.5M Buy
56,446
+6,522
+13% +$1.04M 0.66% 49
2020
Q4 		$7.56M Buy
49,924
+5,378
+12% +$769K 0.65% 52
2020
Q3 		$6.03M Buy
44,546
+8,488
+24% +$1.15M 0.58% 54
2020
Q2 		$4.93M Sell
36,058
-1,305
-3% -$166K 0.54% 53
2020
Q1 		$4.03M Sell
37,363
-14,015
-27% -$1.61M 0.48% 52
2019
Q4 		$6.19M Buy
51,378
+15,031
+41% +$1.68M 0.64% 44
2019
Q3 		$3.62M Sell
36,347
-862
-2% -$90.2K 0.42% 52
2019
Q2 		$4.06M Sell
37,209
-22,377
-38% -$2.38M 0.47% 53
2019
Q1 		$6.66M Buy
59,586
+13,666
+30% +$1.5M 0.81% 39
2018
Q4 		$4.43M Buy
45,920
+1,324
+3% +$141K 0.66% 43
2018
Q3 		$4.96M Buy
44,596
+1,724
+4% +$203K 0.58% 46
2018
Q2 		$4.71M Buy
42,872
+1,282
+3% +$137K 0.61% 46
2018
Q1 		$4.44M Sell
41,590
-17,267
-29% -$1.91M 0.58% 48
2017
Q4 		$6.28M Buy
58,857
+32,286
+122% +$3.45M 0.82% 36
2017
Q3 		$2.96M Buy
+26,571
New +$2.84M 0.44% 48

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alpha Cubed Investments's IBB Position: Q4 2023 in Review

Alpha Cubed Investments sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 2,422 shares — an estimated $296K sold.

Alpha Cubed Investments first reported a position in IBB in Q3 2017 and held it in 25 quarters. The position peaked at $13.9M in Q4 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Alpha Cubed Investments reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Alpha Cubed Investments sold 2,422 iShares Biotechnology ETF shares in Q4 2023, an estimated $296K.
  • Alpha Cubed Investments first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 25 quarters.
  • Alpha Cubed Investments's iShares Biotechnology ETF position peaked at $13.9M in Q4 2021.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Alpha Cubed Investments's 13F filing for Q4 2023, filed 5 Feb 2024.